513 related articles for article (PubMed ID: 29145633)
21. Versatile 3' Functionalization of CRISPR Single Guide RNA.
Palumbo CM; Gutierrez-Bujari JM; O'Geen H; Segal DJ; Beal PA
Chembiochem; 2020 Jun; 21(11):1633-1640. PubMed ID: 31943634
[TBL] [Abstract][Full Text] [Related]
22. Real-time observation of Cas9 postcatalytic domain motions.
Wang Y; Mallon J; Wang H; Singh D; Hyun Jo M; Hua B; Bailey S; Ha T
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33443184
[TBL] [Abstract][Full Text] [Related]
23. A catalogue of biochemically diverse CRISPR-Cas9 orthologs.
Gasiunas G; Young JK; Karvelis T; Kazlauskas D; Urbaitis T; Jasnauskaite M; Grusyte MM; Paulraj S; Wang PH; Hou Z; Dooley SK; Cigan M; Alarcon C; Chilcoat ND; Bigelyte G; Curcuru JL; Mabuchi M; Sun Z; Fuchs RT; Schildkraut E; Weigele PR; Jack WE; Robb GB; Venclovas Č; Siksnys V
Nat Commun; 2020 Nov; 11(1):5512. PubMed ID: 33139742
[TBL] [Abstract][Full Text] [Related]
24. A Cleavage-Responsive Stem-Loop Hairpin for Assaying Guide RNA Activity.
deBoer TR; Wauford N; Chung JY; Torres Perez MS; Murthy N
ACS Chem Biol; 2018 Feb; 13(2):461-466. PubMed ID: 29381046
[TBL] [Abstract][Full Text] [Related]
25. Probing the Dynamics of
Zhdanova PV; Chernonosov AA; Prokhorova DV; Stepanov GA; Kanazhevskaya LY; Koval VV
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163047
[TBL] [Abstract][Full Text] [Related]
26. The post-PAM interaction of RNA-guided spCas9 with DNA dictates its target binding and dissociation.
Zhang Q; Wen F; Zhang S; Jin J; Bi L; Lu Y; Li M; Xi XG; Huang X; Shen B; Sun B
Sci Adv; 2019 Nov; 5(11):eaaw9807. PubMed ID: 31763447
[TBL] [Abstract][Full Text] [Related]
27. Temperature-Responsive Competitive Inhibition of CRISPR-Cas9.
Jiang F; Liu JJ; Osuna BA; Xu M; Berry JD; Rauch BJ; Nogales E; Bondy-Denomy J; Doudna JA
Mol Cell; 2019 Feb; 73(3):601-610.e5. PubMed ID: 30595438
[TBL] [Abstract][Full Text] [Related]
28. Conformational control of DNA target cleavage by CRISPR-Cas9.
Sternberg SH; LaFrance B; Kaplan M; Doudna JA
Nature; 2015 Nov; 527(7576):110-3. PubMed ID: 26524520
[TBL] [Abstract][Full Text] [Related]
29. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
30. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
Briner AE; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for mismatch surveillance by CRISPR-Cas9.
Bravo JPK; Liu MS; Hibshman GN; Dangerfield TL; Jung K; McCool RS; Johnson KA; Taylor DW
Nature; 2022 Mar; 603(7900):343-347. PubMed ID: 35236982
[TBL] [Abstract][Full Text] [Related]
32. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage.
Jiang F; Taylor DW; Chen JS; Kornfeld JE; Zhou K; Thompson AJ; Nogales E; Doudna JA
Science; 2016 Feb; 351(6275):867-71. PubMed ID: 26841432
[TBL] [Abstract][Full Text] [Related]
33. Sequential Activation of Guide RNAs to Enable Successive CRISPR-Cas9 Activities.
Clarke R; Terry AR; Pennington H; Hasty C; MacDougall MS; Regan M; Merrill BJ
Mol Cell; 2021 Jan; 81(2):226-238.e5. PubMed ID: 33378644
[TBL] [Abstract][Full Text] [Related]
34. Mg
Son H; Park J; Hwang I; Jung Y; Bae S; Lee S
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34853172
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3'-terminal segment of guide RNA.
Mekler V; Minakhin L; Semenova E; Kuznedelov K; Severinov K
Nucleic Acids Res; 2016 Apr; 44(6):2837-45. PubMed ID: 26945042
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of duplex DNA destabilization by RNA-guided Cas9 nuclease during target interrogation.
Mekler V; Minakhin L; Severinov K
Proc Natl Acad Sci U S A; 2017 May; 114(21):5443-5448. PubMed ID: 28484024
[TBL] [Abstract][Full Text] [Related]
37. Cryo-EM structures reveal coordinated domain motions that govern DNA cleavage by Cas9.
Zhu X; Clarke R; Puppala AK; Chittori S; Merk A; Merrill BJ; Simonović M; Subramaniam S
Nat Struct Mol Biol; 2019 Aug; 26(8):679-685. PubMed ID: 31285607
[TBL] [Abstract][Full Text] [Related]
38. Structural insights into DNA cleavage activation of CRISPR-Cas9 system.
Huai C; Li G; Yao R; Zhang Y; Cao M; Kong L; Jia C; Yuan H; Chen H; Lu D; Huang Q
Nat Commun; 2017 Nov; 8(1):1375. PubMed ID: 29123204
[TBL] [Abstract][Full Text] [Related]
39. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
Karvelis T; Gasiunas G; Siksnys V
Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
[TBL] [Abstract][Full Text] [Related]
40. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
